CD320 and systemic sclerosis: Although the significance of anti‐CD320 autoantibody in the patient is unclear, vascular and perivascular inflammation caused by SSc and CAPS might lead to the release of CD320 into the circulation, resulting in the production of anti‐CD320 antibody, as CD320 is highly expressed in vascular endothelial cells.10